ARCHIVES

NCI Sets Initial R01 Payline At 18th Percentile Under CR.

This article is from The Cancer Letter archive.

Vol. 26 No. 43 | November 24, 2000

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

September 29, 2006

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007

NCI’s Otis Brawley Named Professor At Emory, Associate Director, Cancer Control, At Winship.

April 20, 2001

Jane Henney Said Tentative Choice For FDA Commissioner

May 22, 1998

Radiation Therapy Combination Better For Treating Cancer Spread To Brain

May 28, 2004

Bristol No Longer Needs Yew From Public Lands, Official Says; Will Use Processed Needles

January 29, 1993